investorscraft@gmail.com

Intrinsic ValueVentas, Inc. (VTR)

Previous Close$69.73
Intrinsic Value
Upside potential
Previous Close
$69.73

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Ventas, Inc. is a leading real estate investment trust (REIT) specializing in healthcare properties, including senior housing communities, medical office buildings, and life science facilities. The company operates through a diversified portfolio that generates stable cash flows from long-term leases and management agreements. Ventas capitalizes on demographic trends, such as an aging population and increasing healthcare demand, positioning itself as a key player in the healthcare real estate sector. Its revenue model combines rental income from tenants with growth opportunities through strategic acquisitions and development projects. The company’s market position is strengthened by partnerships with top-tier healthcare operators, ensuring high occupancy rates and sustainable returns. Ventas differentiates itself through scale, operational expertise, and a focus on high-quality assets in attractive markets, making it a preferred choice for investors seeking exposure to healthcare real estate.

Revenue Profitability And Efficiency

Ventas reported revenue of $4.92 billion for the period, with net income of $81.2 million and diluted EPS of $0.19. Operating cash flow stood at $1.33 billion, reflecting strong cash generation from its property portfolio. Capital expenditures totaled $603.8 million, indicating ongoing investments in property maintenance and development. The company’s ability to convert revenue into cash flow underscores its operational efficiency and disciplined cost management.

Earnings Power And Capital Efficiency

Ventas demonstrates solid earnings power, supported by its diversified healthcare property portfolio. The company’s capital efficiency is evident in its ability to generate substantial operating cash flow relative to its revenue. With $897.9 million in cash and equivalents, Ventas maintains liquidity to fund growth initiatives while managing its $13.7 billion debt load. The balance between earnings and capital deployment highlights its strategic focus on sustainable growth.

Balance Sheet And Financial Health

Ventas’s balance sheet reflects a robust yet leveraged position, with total debt of $13.7 billion offset by $897.9 million in cash and equivalents. The company’s financial health is supported by its ability to generate consistent cash flow, which aids in servicing debt and funding dividends. Its REIT structure necessitates a focus on maintaining liquidity and prudent leverage ratios to sustain dividend payments and growth investments.

Growth Trends And Dividend Policy

Ventas has maintained a dividend per share of $1.80, appealing to income-focused investors. Growth trends are driven by demographic tailwinds in healthcare demand and strategic property acquisitions. The company’s focus on high-quality assets and operator partnerships positions it for long-term growth, though near-term performance may be influenced by macroeconomic conditions and healthcare sector dynamics.

Valuation And Market Expectations

Ventas’s valuation reflects its position as a leading healthcare REIT, with market expectations centered on its ability to sustain cash flow growth and dividend payments. The company’s diversified portfolio and demographic advantages provide a foundation for stable performance, though investor sentiment may fluctuate with interest rate movements and sector-specific trends.

Strategic Advantages And Outlook

Ventas benefits from strategic advantages, including a diversified healthcare property portfolio and strong operator relationships. The outlook remains positive, supported by long-term demographic trends and the company’s disciplined capital allocation. Challenges include managing leverage and navigating sector-specific risks, but Ventas is well-positioned to capitalize on growth opportunities in the healthcare real estate market.

Sources

Company filings, investor presentations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount